PubRank

Rosalie M Luiten

Author PubWeight™ 25.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006 4.84
2 Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 2012 1.81
3 Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol 2011 1.71
4 Telomerase levels control the lifespan of human T lymphocytes. Blood 2003 1.59
5 Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009 1.56
6 In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. Pigment Cell Melanoma Res 2011 1.50
7 Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun 2008 1.31
8 Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev 2006 1.12
9 First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res 2010 0.96
10 Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity. Pigment Cell Melanoma Res 2011 0.92
11 T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clin Cancer Res 2011 0.92
12 Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol 2012 0.89
13 T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol 2006 0.88
14 Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One 2010 0.88
15 Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice. Cancer Res 2004 0.87
16 High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Horm Res Paediatr 2013 0.83
17 Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma. Anticancer Res 2011 0.83
18 Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells. Eur J Immunol 2012 0.79
19 The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo. Pigment Cell Melanoma Res 2014 0.77
20 Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. Exp Dermatol 2014 0.75
21 Skin immune system. Cancer Treat Res 2009 0.75